Filgotinib
Back to searchMolecule Structure
Scientific Name
Filgotinib
Description of the Drug
Filgotinib is a Janus kinase (JAK) 1 selective inhibitor used to treat cases of rheumatoid arthritis that are unresponsive to conventional treatments.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14845
http://www.drugbank.ca/drugs/DB14845
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tyrosine-protein kinase JAK1 | SINGLE PROTEIN | INHIBITOR | CHEMBL2835 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL253559 |
| Human Metabolome Database | HMDB0252256 |
| DrugBank | DB14845 |
| PubChem: Thomson Pharma | 103906062 |
| PubChem | 49831257 |
| LINCS | LSM-45924 |
| Nikkaji | J3.339.895F |
| PDBe | 2HB |
| BindingDB | 103727 |
| EPA CompTox Dashboard | DTXSID80152935 |
| DrugCentral | 5419 |
| ChemicalBook | CB52621138 |
| Guide to Pharmacology | 7913 |
| ZINC | ZINC000096174616 |
